API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. ST /
  3. ONCO.ST

Oncopeptides AB (ONCO ST) stock market data APIs

kr1.72 0.18(11.7%) as of November 22, 2024
Price chart is built with Anychart

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company also engages in the research for small popypeptide based killer engages for the treatment of RRMM and hematological or solid tumors; and other peptide-drug conjugates for glioblastoma and hematological or solid tumors. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden

Oncopeptides AB Financial Data Overview

1.876
1.72
-
1.384
1.238
1.426-9.182
325 M
211 M
27 071 K
-0.2851
-0.359
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ONCO',
Type: 'Common Stock',
Name: 'Oncopeptides AB',
Exchange: 'ST',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'Sweden',
CountryISO: 'SE',
OpenFigi: NULL,
ISIN: 'SE0009414576',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Oncopeptides AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 27 071 K
  • EBITDA -277 724 000
  • Earnings Per Share -1.44
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Oncopeptides AB Earnings via APIs

  • Latest Release 2024-11-07
  • EPS/Forecast NaN

Get Oncopeptides AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Oncopeptides AB latest news via APIs

Oncopeptides Chief Financial Officer Holger Lembrer takes office today

STOCKHOLM, Jan. 18, 2023 /PRNewswire/ -- Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for difficult-to-treat...
  • BIOTECH COMPANY
  • CORPORATE COMMUNICATIONS
  • HEMATOLOGICAL DISEASES
  • HOLGER LEMBRER
  • MONICA SHAW
  • NASDAQ STOCKHOLM
  • ONCO
  • ONCOPEPTIDES
  • ONCOPEPTIDES AB

Oncopeptides appoints Holger Lembrer as Chief Financial Officer

STOCKHOLM, Jan. 11, 2023 /PRNewswire/ -- Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological dise...
  • ANNIKA MUSKANTOR
  • FINANCIAL CONTROLLER
  • HEMATOLOGICAL DISEASES
  • HOLGER LEMBRER
  • INTERIM CFO
  • NASDAQ STOCKHOLM
  • ONCOPEPTIDES
  • ONCOPEPTIDES AB
  • ONCOPEPTIDES HOLGER LEMBRER
  • RESEARCH AND DEVELOPMENT
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com